...
首页> 外文期刊>Journal of biomedical materials research, Part A >The effect of active ingredient-containing chitosan/polycaprolactone nonwoven mat on wound healing: In vitro and in vivo studies
【24h】

The effect of active ingredient-containing chitosan/polycaprolactone nonwoven mat on wound healing: In vitro and in vivo studies

机译:含活性成分的壳聚糖/聚己内酯非织造垫对伤口愈合的影响:体外和体内研究

获取原文
获取原文并翻译 | 示例
           

摘要

The use of an electrospun polycaprolactone (PCL) nonwoven mat that is coated with a layer of chitosan (CS) containing active ingredient [tea tree oil (TTO)] represents an effective strategy for producing functional dressings. CS-coated porous PCL nonwoven mat (CS3/PCLNM) with various concentrations of active ingredients were produced and investigated. In vitro, active ingredient-containing CS3/PCLNM is effective in inhibiting the formation of nitrite and the growth of Staphylococcus aureus. Both active ingredient TTO and CS have been proven to reach their maximum amount of releases within 24 h of contact with water-based environment. In vivo, full-thickness skin removal (1.2 cm × 1.2 cm) was performed on the back of the C57BL6/J mice in noninfected and infected animal models. Four groups of functional dressings were tested in this work including Tegderm?, PCLNM, CS3/PCLNM, and 100 μL TTO-CS3/PCLNM. After 7 days post-treatment, the bacterial levels were found to be significantly lower in both CS3/PCLNM and 100 μL TTO-CS3/PCLNM-treated groups than in the control group (81.6 ± 18.1% and 93.7 ± 9.57% of reductions in the bacterial load in the pus relative to the control group, respectively). Additionally, based on the histological analyses, the 100 μL TTO-CS3/PCLNM-treated group outperformed all other groups in wound healing.
机译:使用涂有含有活性成分[茶树油(TTO)的壳聚糖(CS)涂有一层壳聚糖(CS)的电纺多丙酮(PCL)非织造垫代表了生产功能敷料的有效策略。产生并研究具有各种浓度活性成分的Cs-涂覆的多孔PCL非织造垫(CS3 / PCLNM)。体外,含有活性成分的CS3 / PCLNM是有效抑制亚硝酸盐的形成和金黄色葡萄球菌的生长。已证明活性成分TTO和CS均已被证明在与水性环境接触的24小时内达到最大释放量。在体内,在无感染和受感染的动物模型的C57BL6 / J小鼠的背面上进行全厚的皮肤去除(1.2cm×1.2cm)。在该工作中测试了四组功能敷料,包括TEGDERM?,PCLNM,CS3 / PCLNM和100μLTTO-CS3 / PCLNM。治疗后7天后,在CS3 / PCLNM和100μLTTO-CS3 / PCLNM处理的组中发现细菌水平显着低于对照组(81.6±18.1%和93.7±9.57%的减少PUS相对于对照组的细菌载荷分别为对照组)。另外,基于组织学分析,100μLTTO-CS3 / PCLNM处理基团优于伤口愈合中的所有其他基团。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号